Drugs / 4 factor Prothrombin Complex Concentrates
4 factor Prothrombin Complex Concentrates
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05738642 | Aug 2023 → Jun 2025 | — | Second Affiliated Hospital, School of Medicine, Zhejiang University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 4 factor Prothrombin Complex Concentrates | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05738642 ↗ |
| Modality | Protein / enzyme biologic | “4F-PCC is a compound preparation containing coagulation factors Ⅱ, VII, IX and X separated from fresh plasma of healthy people.” NCT05738642 ↗ |
| Route | Intravenous | “intravenous infusion” NCT05738642 ↗ |